PRFX PRF Technologies Ltd.

BEARISH Impact: 7/10 6-K
Horizon immediate Filed May 7, 2026 Processed 1mo ago SEC 0001178913-26-002448
Notable filing: 6-K
Latest settled — T+20d
PRFX ▼ -18.04% at T+20d
SHORT call ✓ call won +18.04% · α vs SPY +18.06% · entry $1.94 → $1.59
Next anchor: T+60d in 8w
Currently $1.43 · +26.29% from $1.94 entry (call sign-flipped)
Entry anchored
May 7, 2026
via day open
T+1d
-6.19%
call +6.19% · α +6.42%
$1.82
settled 5w ago
T+5d
-18.56%
call +18.56% · α +20.02%
$1.58
settled 27d ago
T+20d
-18.04%
call +18.04% · α +18.06%
$1.59
settled 5d ago
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

PRF Technologies entered into a standby equity purchase agreement with Yorkville for up to $10 million, pricing at 97% of the lowest daily VWAP over three days. With a $2M market cap and only 844K shares outstanding, this facility poses severe dilution risk and signals acute capital needs following the prior going concern warning.

Actionable Insight

Expect significant downward pressure on the stock as the market prices in the dilutive facility. Monitor the first advance notice and effectiveness of the registration statement, which will trigger selling by Yorkville. The company's cash runway may be extended, but at extreme cost to existing shareholders.

Key Facts

  • Up to $10M standby equity purchase agreement with YA II PN (Yorkville) over 36 months
  • Purchase price set at 97% of the lowest VWAP during a 3-day pricing period
  • Company issued 12,192 Commitment Shares and 12,192 Structuring Shares as fees
  • Current outstanding shares: 844,372; warrants: 2,894,259 to purchase 448,797 shares
  • Prior 20-F (Mar 26, 2026) reported going concern warning and $4.1M cash

Financial Impact

Potential dilution of up to ~$10M at current market prices, representing several times the current market cap of $2M

dilutioncash

Risk Factors

  • Massive dilution to existing shareholders
  • Going concern risk exacerbated by reliance on toxic financing
  • Stock price likely to decline on overhang and future selling by Yorkville

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001178913-26-002448
Document: zk2635233.htm0001178913-26-002448
Document: 0001178913-26-002448-index-headers.html0001178913-26-002448
Document: 0001178913-26-002448-index.html0001178913-26-002448
Document: 0001178913-26-002448.txt0001178913-26-002448
7 reports for PRFX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PRFX — sortable, filterable
Type Now
May 28, 2026
13d ago
6-K
NEUTRAL ★ 3/10
$1.37 $1.86▲ +35.77%▲ +35.81%$1.43 (+4.38%)
May 26, 2026
15d ago
6-K
NEUTRAL ★ 4/10
$1.34 $2.02▲ +50.75%▲ +49.66%$1.43 (+6.72%)
May 26, 2026
15d ago
Press Release
BULLISH ★ 5/10
$1.34 $2.02▲ +50.75%▲ +49.66%$1.43 (+6.72%)
May 7, 2026
4w ago
6-K
BEARISH ★ 7/10
$1.94 $1.58▲ +18.56%▲ +20.02%$1.43 (+26.29%)
Apr 28, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$2.04 $1.97▼ −3.43%▼ −5.12%$1.43 (−29.90%)
Mar 27, 2026
10w ago
6-K
MIXED ★ 6/10
$2.08 $2.53▲ +21.63%▲ +17.77%$1.43 (−31.25%)
Mar 26, 2026
10w ago
20-F
BEARISH ★ 6/10
$2.08 $2.53▼ −21.63%▼ −17.77%$1.43 (+31.25%)
Showing 7 of 7

US Market Status

Market Open — Closes in 2h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access